Powerful cancer pain drugs were given to patients with other conditions who cannot tolerate them. A program to curb the practice was run by companies that sell the drugs. By Emily Baumgaertner The ...

Cephalon Inc. reacquired rights to its cancer pain product, Actiq, in 12 countries from Elan Pharma Ltd., a subsidiary of Elan Corp. plc, to the tune of $50 million in cash. Actiq is one of three ...

Cephalon Inc. on Wednesday confirmed it is suing generic drug developer Watson Pharmaceuticals Inc. over that company's plan to make a generic version of Cephalon's sleep disorder drug Nuvigil.

NEW YORK, Dec 8 (Reuters) - Cephalon Inc's experimental cancer drug Treanda appeared to be effective in patients whose non-Hodgkin's lymphoma (NHL) had progressed during or following treatment with ...

WHAT: Cephalon, Inc., (Nasdaq: CEPH) will hold a public memorial service to celebrate the life of the company's founder and late Chairman and CEO, Dr. Frank Baldino, Jr. WHEN: Tuesday, February 1, ...

TORONTO (Reuters) - Valeant Pharmaceuticals International Inc is expected to turn its attention to other acquisition targets in the specialty pharmaceuticals landscape after pulling out of the race to ...

FRAZER, Pa. and MELBOURNE, Australia, March 28, 2011 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH) and ChemGenex Pharmaceuticals Limited (ASX: CXS) today jointly announced that Cephalon 's ...

Attorney General Mark Herring filed suit this week against opioid manufacturer Teva Pharmaceuticals, USA, Inc. and its predecessor, Cephalon, Inc. for engaging in what he alleges is an unlawful, ...

Cephalon, Inc. (CEPH) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the occasion, Kevin Buchi, Chief Executive Officer of Cephalon, Inc. (CEPH), will ring the Opening ...

Drug maker Valeant Pharmaceuticals, which moved its headquarters from Aliso Viejo to Canada late last year, is the story of the day on Wall Street with a hostile takeover bid for Pennsylvania ...

On April 30, 2024, in Himawan, et al. v. Cephalon, Inc., et al., the Delaware Court of Chancery held that the defendant acquiror complied with its contractual obligations to use commercially ...